Metrnl and Cardiomyopathies: From Molecular Mechanisms to Therapeutic Insights
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Cardiomyopathies, a diverse group of diseases affecting the heart muscle, continue to pose significant clinical challenges due to their complex aetiologies and limited treatment options targeting underlying genetic and molecular dysregulations. Emerging evidence indicates that Metrnl, a myokine, adipokine and cardiokine, plays a significant role in the pathogenesis of various cardiomyopathies. Therefore, the objective of this review is to examine the role and mechanism of Metrnl in various cardiomyopathies, with the expectation of providing new insights for the treatment of these diseases.
References
1.
Cen T, Mai Y, Jin J, Huang M, Li M, Wang S
. Interleukin-41 diminishes cigarette smoke-induced lung inflammation in mice. Int Immunopharmacol. 2023; 124(Pt A):110794.
DOI: 10.1016/j.intimp.2023.110794.
View
2.
Oduro P, Zheng X, Wei J, Yang Y, Wang Y, Zhang H
. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Acta Pharm Sin B. 2022; 12(1):50-75.
PMC: 8799861.
DOI: 10.1016/j.apsb.2021.05.011.
View
3.
Ma X, Geng K, Law B, Wang P, Pu Y, Chen Q
. Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes. Cell Biol Toxicol. 2022; 39(1):277-299.
PMC: 10042943.
DOI: 10.1007/s10565-021-09692-z.
View
4.
Chen L, Qin Y, Liu B, Gao M, Li A, Li X
. PGC-1-Mediated Mitochondrial Quality Control: Molecular Mechanisms and Implications for Heart Failure. Front Cell Dev Biol. 2022; 10:871357.
PMC: 9199988.
DOI: 10.3389/fcell.2022.871357.
View
5.
Baht G, Bareja A, Lee D, Rao R, Huang R, Huebner J
. Meteorin-like facilitates skeletal muscle repair through a Stat3/IGF-1 mechanism. Nat Metab. 2020; 2(3):278-289.
PMC: 7504545.
DOI: 10.1038/s42255-020-0184-y.
View